Long QT syndrome in chromosome 7q35q36.3 deletion involving KCNH2 gene: Warning for chlorpheniramine prescription

Mol Genet Genomic Med. 2019 Sep;7(9):e855. doi: 10.1002/mgg3.855. Epub 2019 Jul 25.

Abstract

Background: The deletion of the distal 7q region is a rare chromosomal syndrome characterized by wide phenotypic manifestations including growth and psychomotor delay, facial dysmorphisms, and genitourinary malformations.

Methods: We describe a 6-year-old child with a 12-Mb deletion of the region 7q35q36.3.

Results: Among the deleted genes, two genes have cardiac implications: PRKAG2 (OMIM #602743), associated with hypertrophic cardiomyopathy, cardiac conduction disease, and sudden death, and KCNH2 (OMIM #152427), coding for a cardiac potassium channel involved in long QT syndrome, unmasked by the chlorpheniramine treatment. At same time, the SHH gene (OMIM #600725), encoding sonic hedgehog, a secreted protein that is involved in the embryonic development, is deleted.

Conclusion: Our report underlines potential cardiac complications linked to the common pharmacological treatment in this rare multiorgan and proteiform disease.

Keywords: chlorpheniramine; chromosome 7q35q36.3 deletion; long QT syndrome; syncope.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Chlorpheniramine / adverse effects
  • Chlorpheniramine / therapeutic use
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 7*
  • DNA Copy Number Variations
  • Drug Prescriptions
  • ERG1 Potassium Channel / genetics*
  • Electrocardiography
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Humans
  • Long QT Syndrome / diagnosis
  • Long QT Syndrome / drug therapy
  • Long QT Syndrome / genetics*
  • Male

Substances

  • ERG1 Potassium Channel
  • KCNH2 protein, human
  • Chlorpheniramine